The FDA Just Showed Ketamine Clinics Exactly How a Crackdown Starts. Almost Nobody Noticed
The FDA's crackdown on compounded GLP-1 marketing is a preview for ketamine clinics. Your website copy may be your biggest liability.
Read More
FDA Grants Priority Vouchers to Three Psychedelic Drug Programs
The FDA's decision could deliver the first psychedelic medicine approved by the FDA as soon as this summer.
Read More
FDA Grants Breakthrough Therapy Status to Psychedelic Inspired Postpartum Depression Drug
Reunion Neuroscience announced that its drug luvesilocin received Breakthrough Therapy Designation for the treatment of postpartum depression.
Read More
FDA Says Psychedelic Drug Applications Now “Fully a Third” of Workload
Federal officials are signaling growing momentum behind psychedelic drug development. The flood of applications reflects broad enthusiasm.
Read More